Get started

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

Updates arrive automatically.

  • Malaysia: TotalEnergies Signs Agreements to Acquire Operated Interest in Two Major Offshore Gas Fields
    PR·

    Malaysia: TotalEnergies Signs Agreements to Acquire Operated Interest in Two Major Offshore Gas Fields

    TotalEnergies (PARIS:TTE) (LSE:TTE) (NYSE:TTE) announces the signing of agreements with PETRONAS Carigali Sdn Bhd (PCSB), PTTEP and KUFPEC to acquire a 30% operated interest in the Lang Lebah and B14 gas fields, located off the coast of Sarawak, Malaysia. Lang Lebah, one of Malaysia’s largest offshore gas discoveries, and the nearby B14 field are planned to be developed as an integrated project. This combined development is expected to unlock more than 6.5 trillion cubic feet of gas resources (equivalent to more than 1 billion barrels of oil equivalent) to supply the existing Malaysia LNG liquefaction plant with a production plateau of around 10 billion cubic meters per annum (BCMA). "T

    $TTE
  • Kosmos Energy Announces Third Quarter 2026 Results
    PR·

    Kosmos Energy Announces Third Quarter 2026 Results

    Kosmos Energy Ltd. ("Kosmos" or the "Company") (NYSE/LSE: KOS) announced today its financial and operating results for the third quarter of 2026. For the quarter, the Company generated a net loss of $43 million, or $0.07 per diluted share. When adjusted for certain items that impact the comparability of results, the Company generated an adjusted net income(1) of $35 million, or $0.06 per diluted share for the third quarter of 2026. THIRD QUARTER 2026 AND POST QUARTER END HIGHLIGHTS Net Production(2): ~69,200 barrels of oil equivalent per day (boepd), up ~6% versus third quarter 2025 (~17% excluding Equatorial Guinea)Revenues: $410 million, or $7

    $KOS
  • Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation
    PR·

    Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation

    Björn Tackenberg, M.D. Ph.D. FEAN FAAN, Professor of Neurology, will lead Oculis’ global integrated scientific strategy supporting the advancement of Privosegtor and its expansion into new therapeutic applications Aaron Tansy, M.D., appointed as Vice President, Development Franchise Head, Neurology, brings complementary expertise in neurology and global clinical development ZUG, Switzerland, November 2, 2026 -- Oculis Holding AG (NASDAQ:OCS, XICE: OCS)) ("Oculis"), a global biopharmaceutical company focused on breakthrough innovations in neuro-ophthalmology and ophthalmology, today announced the appointment of Björn Tackenberg, M.D., Ph.D., FEAN, FAAN and Professor of Neurology as its new

    $OCS
  • Apollo Announces the Launch of European Credit Company
    PR·

    Apollo Announces the Launch of European Credit Company

    ECC is backed by long-term investors led by Apollo as well as ADIC, Athora, Norinchukin, Standard Chartered and Aranda Principal Strategies; launches with €10 billion of lending capacity

    $APO
  • Kosmos Energy Announces Successful Amendment and Extension of Reserve-Based Lending Facility
    PR·

    Kosmos Energy Announces Successful Amendment and Extension of Reserve-Based Lending Facility

    Kosmos Energy (NYSE/LSE: KOS) ("Kosmos" or the "Company") today announced the successful completion of the amendment and extension of its reserve-based lending ("RBL") facility. This represents another important step in the Company's ongoing efforts to strengthen balance sheet resilience, improve liquidity and extend debt maturities. The amended facility maintains a facility size and total commitments of $1.2 billion, with $750 million drawn at close. The facility has a tenor of approximately six and a half years, which extends the final maturity date from December 2029 to April 2033 with the facility size beginning to amortize after three years.

    $KOS
  • Borr Drilling Limited - Prospector 5 Rig Incident Update - November 2, 2026
    PR·

    Borr Drilling Limited - Prospector 5 Rig Incident Update - November 2, 2026

    Borr Drilling Limited (NYSE:BORR) (OSE: BORR) ("Borr Drilling" or the "Company") provides an update on the Prospector 5 incident offshore Gabon, first announced by the Company on October 25, 2026. As part of the ongoing search and rescue operations, the body of a fourth individual has been located. All four located individuals have been recovered and are in the process of being transported to Port Gentil, Gabon. Search efforts continue for the remaining individual who is still unaccounted for. The Company has engaged a globally recognized classification society with extensive experience in offshore and maritime incident investigations to conduct

    $BORR
  • Blackstone and Leading Canadian Institutional Investors Announce $3.1B Investment in Mitsubishi Corporation’s Interest in LNG Canada
    PR·

    Blackstone and Leading Canadian Institutional Investors Announce $3.1B Investment in Mitsubishi Corporation’s Interest in LNG Canada

    Investor group includes CPP Investments, OMERS, IMCO and PSP Investments Blackstone today announced that funds managed by Blackstone Credit & Insurance, in partnership with leading Canadian institutional investors, have agreed to invest $3.1 billion to acquire a 49.9% non-controlling interest in a Mitsubishi Corporation ("MC") subsidiary that holds MC’s interest in the LNG Canada liquefaction business. The Blackstone-led investor group includes Canada Pension Plan Investment Board (CPP Investments), through wholly owned subsidiaries of CPPIB Credit Investments Inc., Ontario Municipal Employees Retirement System (OMERS), the Investment Management Corporation of Ontario (IMCO) and The Pub

    $BX
  • Lazard Completes Its Acquisition of Campbell Lutyens and Launches Lazard CL, the Global Leader for the Next Era of Private Capital
    PR·

    Lazard Completes Its Acquisition of Campbell Lutyens and Launches Lazard CL, the Global Leader for the Next Era of Private Capital

    Lazard, Inc. (NYSE:LAZ) today announced the completion of the firm's acquisition of Campbell Lutyens and the launch of Lazard CL, the global leader in private capital advisory. The transaction, first announced on April 30, 2026, brings together top-tier bankers and worldwide operations across Lazard's private capital advisory and the Campbell Lutyens businesses. The establishment of Lazard CL marks a milestone in the Lazard 2030 strategy to deliver long-term, profitable growth, expanding the solutions provided to clients and further diversifying the firm's revenue. Peter Orszag,

    $LAZ
  • “e.l.f. Made to Stand Out”: e.l.f. Creates Handcrafted Holiday Campaign to Celebrate Self Expression, Individuality and Inclusivity
    PR·

    “e.l.f. Made to Stand Out”: e.l.f. Creates Handcrafted Holiday Campaign to Celebrate Self Expression, Individuality and Inclusivity

    Narrated by Alan Cumming, e.l.f. shares a holiday tale for everyone who was never made to fit the mold e.l.f. Brands, including e.l.f. Cosmetics, e.l.f. SKIN and e.l.f. Hair, part of e.l.f. Beauty (NYSE:ELF), is celebrating what makes every eye, lip and face one of a kind with "e.l.f. Made to Stand Out," the brand’s first-ever holiday campaign. Created entirely through handmade stop-motion animation, marking another eyes.lips.first for e.l.f., the campaign puts an unmistakable e.l.f. twist on nostalgic holiday storytelling to celebrate a simple truth: your difference is lowkey your gift. This press release features multimedia. View the full release here: https://www.businesswire.com/news

    $ELF
  • FTI Consulting Appoints Daniel Heywood as Senior Managing Director in Brisbane
    PR·

    FTI Consulting Appoints Daniel Heywood as Senior Managing Director in Brisbane

    FTI Consulting, Inc. (NYSE:FCN) today announced the appointment of Daniel Heywood as a Senior Managing Director in the Forensic and Litigation Consulting segment. He will help clients navigate complex commercial disputes, investigations and regulatory matters. Mr. Heywood, who is based in Brisbane, brings more than 17 years of forensic accounting experience. His areas of expertise include the quantification of economic loss, contract and post-acquisition disputes, class actions, professional negligence matters, insurance claims, insolvency litigation, forensic investigations, asset tracing and wage underpayment matters. "Daniel bring

    $FCN
  • Hotel101-Madrid Hits Record High of US$3.28 Million Monthly Recurring Revenues From October 1 to 31, 2026 With 97.41% Occupancy
    PR·

    Hotel101-Madrid Hits Record High of US$3.28 Million Monthly Recurring Revenues From October 1 to 31, 2026 With 97.41% Occupancy

    Hotel101-Madrid, the 680-room global prototype, has recorded its strongest monthly performance to date, providing further support for the Company’s asset-light condotel model as it advances its international expansion. Latest Photo of 680-room Hotel101-

    $HBNB
  • MicroVision Expands Collaboration with FieldAI Across Government and Industrial Autonomous Systems Programs
    PR·

    MicroVision Expands Collaboration with FieldAI Across Government and Industrial Autonomous Systems Programs

    MicroVision, Inc. (NASDAQ:MVIS), a leader in advanced perception solutions for industrial, security and defense, and automotive applications, today announced an expanded collaboration with FieldAI, a developer of autonomous robotic systems for government and industrial applications. MVIS)" data-mce-style="display: block; margin-left: auto; margin-right: auto;" height="338" src="https://ml.globenewswire.com/Resource/Download/1da378d3-deeb-4d93-9482-ea28611b4e49/picture1.png" style="display:block; margin-left:auto; margin-right:auto;" width="600" data-dpi="96" data-caption="MicroVision, Inc. (NASDAQ:MVIS)" data-filename="Picture1.png"> The c

    $MVIS
  • FF EAI Robotics Ecosystem (FFR) CEO YT Jia Shares Weekly Investor Update: Recaps FFR's Listing Closing and First Investor Day in New York; FFR Sold and Shipped 351 Robot Devices in October, Setting Another Monthly Record
    PR·

    FF EAI Robotics Ecosystem (FFR) CEO YT Jia Shares Weekly Investor Update: Recaps FFR's Listing Closing and First Investor Day in New York; FFR Sold and Shipped 351 Robot Devices in October, Setting Another Monthly Record

    FF EAI Robotics Ecosystem Inc. ("FFR") (NASDAQ:FFR), has officially listed on the U.S. stock market as the first pure-play Four-Core Full-Stack AI humanoid and bionic robotics company.FFR sold and shipped 351 devices in October, setting another monthly record. Since the Company began sales and deliveries at the end of February, cumulative sales and shipments have reached 1,168 units, topping 1,000 for the first time, and continuing to deliver at a positive gross margin.FFR and FFAI's New York regional operations are now up and running and are now officially recruiting business partners. The first phase covers New York, New Jersey, Massachusetts, southwestern Connecticut, and eastern Pennsylv

    $FFR
  • Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR Sold and Shipped 351 Robot Devices in October, Setting Another Monthly Record and Bringing Cumulative Sales and Shipments to 1,168 Units
    PR·

    Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR Sold and Shipped 351 Robot Devices in October, Setting Another Monthly Record and Bringing Cumulative Sales and Shipments to 1,168 Units

    FF EAI Robotics Ecosystem Inc. ("FFR") (NASDAQ:FFR), has officially listed on the U.S. stock market as the first pure-play Four-Core Full-Stack AI humanoid and bionic robotics company. FFR sold and shipped 351 devices in October, setting another monthly record. Since the Company began sales and deliveries at the end of February, cumulative sales and shipments have reached 1,168 units, topping 1,000 for the first time, and continuing to deliver at a positive gross margin. FFR and FFAI’s New York regional operations are now up and running and is now officially recruiting business partners. The first phase covers New York, New Jersey, Massachusetts, southwestern Connecticut, and eastern

    $FFAI$FFR
  • HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
    PR·

    HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan

    — Follows US FDA new drug application submission in September 2026, marking important global regulatory progress — — Filings supported by positive SAFFRON global Phase III data demonstrating statistically significant and clinically meaningful PFS and OS improvements — — Data selected for ESMO 2026 Presidential Symposium and simultaneously published in The New England Journal of Medicine —

    $HCM
  • Mesoblast Board Changes
    PR·

    Mesoblast Board Changes

    Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced rotational changes and retirement of certain members of its Board, and reiterated its intention to add new members with the requisite global commercial experience in the biopharmaceutical sector in line with its next phase of commercial delivery and growth. After 12 years of serving on the Board since 2014, Mr William Burns will retire from the Board at the Company’s 2026 Annual General Meeting. Ms Jane Bell AM will take over as Chair of the Nomination and Remuneration Committee, having been co-Chair with Mr Burns

    $MESO
  • Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System
    PR·

    Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System

    SonicForce is an investigational coronary intravascular lithotripsy (IVL) system that uses acoustic pressure waves, similar to those used to break up kidney stones, to crack calcium in coronary arteries and restore blood flowThe system is designed to bring purposeful innovation to treating complex coronary calcium, with longer treatment lengths, more pulses and enhanced catheter deliverabilityApproval of the investigational system would further strengthen Abbott's comprehensive coronary devices portfolio, complementing its advanced imaging, lesion preparation and stent technologies

    $ABT
  • Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026
    PR·

    Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026

    Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced 30-day clinical and hemodynamic outcomes for the Medium-size DurAVR® Transcatheter Heart Valve (THV) in twenty-two severe aortic stenosis patients with medium aortic annuli (aortic annulus area 492 ± 38 mm2). The DurAVR THV demonstrated single digit mean gradients, large effective orifice areas (EOAs), no moderate or severe paravalvular leaks and no valve related mortality,

    $AVR